Arcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of ($4.86), versus $0.00 reported last year.

“With the launch of our GoodWheat™ brand and notable technical achievements in our Resistant Starch and Reduced Gluten wheat products, 2018 is shaping up to be a game-changing year at Arcadia,” said Raj Ketkar, president and CEO. “We made a strong start in our commercialization plans for our wheat quality portfolio in the first quarter, all the while containing our operating costs, leading to another year-over-year reduction in our quarterly operating loss.”

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.